Lung Ambition Alliance Advisory Board Meeting
Pre-meeting survey

8. AstraZeneca prioritises lung cancer screening as a very important strategy in advancing lung cancer outcomes and reducing mortality among patients. We would like to invite you to be our steering committee member, and to advise and steer key initiatives in lung cancer screening in Hong Kong. The scope of work can be further discussed to suit the convenience of each committee member.
Do you agree to be a steering committee member and work with AstraZeneca in advancing lung cancer screening in Hong Kong?
*